Related posts

Stocks rebound, megatech soars after the bell
Investor Insights

This summary was created by AI, based on 2 opinions in the last 12 months.

Corteva Inc. has been identified as a slow-moving stock, but it's on the verge of breaking out of its current pattern, although not as rapidly as tech stocks. Recent financial results have shown significant improvements, including a 280 basis point increase in operating EBITDA margins and a remarkable 40% increase in free cash flow, supported by a substantial $1 billion share buyback program announced for this year. The relative strength index (RSI) is currently at 58, suggesting the stock is not in overbought territory, which experts view positively. With a unique business model and a rock-solid balance sheet, Corteva is recognized as a solid investment, displaying double-digit growth potential while being somewhat sensitive to corn prices. Overall, the consensus is that Corteva possesses a strong operational foundation and growth trajectory, appealing to investors looking for stability and reliable performance.

Consensus
Positive
Valuation
Fair Value
BUY

A slow mover, but is in the process of breaking out, though not like a tech stock. Their last report showed operating EBITDA margin +280 basis points, free cash flow +40%, and announced a $1 billion share buyback for this year. RSI is 58, so not overbought. Likes their golden cross.

PAST TOP PICK
(A Top Pick Aug 04/23, Down 3%)

Phenomenal business. Somewhat sensitive to corn prices. Back to a double-digit grower. Rock-solid balance sheet and free cashflow. Unique and great.

TOP PICK

Seed & crop protection company.
Strong demand for agriculture products.
Double digit earnings growth.
Pristine balance sheet with little debt.
Steady dividend that is reliable. 
Well run business with excellent management.

DON'T BUY

Is expensive vs. Deere and revenue growth is only 6% over the last three years. The biotech story in agriculture has to be a catalyst to get him excited and that's a stretch.

BUY

The ad market is soggy now, but will come back. He is bullish this long term.

BUY

Nice top and bottom line beat. 11% organic growth driven by strong demand for agricultural commodities.

BUY ON WEAKNESS
They make seeds and pesticides for agriculture, a sector which boomed this year. Corteva sales jumped this year, but will continue in years ahead. This isn't a fertilizer play (which is a trade, not investment). Farmers are and will buy Corteva's genetically modified seeds for the long-term. Despite its good run, CTVA still trades under 19x forward earnings.
Unspecified
It is probably the only crop protection and seeds business that is publicly traded. We need more productive seeds and chemicals in the agricultural business. There is a very low supplies to use ratio. The tight global grain market is due to the Ukraine/Russia conflict so Cortiva is important to the solution of the problem.
BUY
Necessary for food production in times of climate change. Management's done a great job, evolving their portfolio into higher margin businesses and products. Almost a tech company.
BUY
Crop science company, competing with Monsanto but without the social issues. Phenomenal R&D. Unique products. Huge impact in emerging markets. Helps with food security. Very well run, great cashflow generator, pretty good earnings growth. His pick in the sector.
BUY

Was spun off from the Dow-Dupont merger. We're seeing a bull market in the fertilizer market. Corteva's genetically modified seeds produce the best yields in the business. A JPMorgan reports forecasts low agricultural yields and higher demand short-term.

BUY
NTR vs. Corteva He owns both. Cortevais into crop protection. Nutrien is in fertilizer. Both are strongly correlated to commodity prices, however. Nutrien pays a healthy dividend, but Corteva offers better growth and could benefit from ongoing climate change problems. Both are best-in-class businesses.
TOP PICK
They don’t have the Monsanto issues. People don’t want to buy GMO foods but the fact is that it is how we feed places like India and China where people used to die of starvation when there were droughts. He expects earnings growth of 15% for the next few years. It will get better over the next few years. (Analysts’ price target is $32.81)
Showing 1 to 13 of 13 entries
  • «
  • 1
  • »

Corteva Inc.(CTVA-N) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 2

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 2

Stockchase rating for Corteva Inc. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Corteva Inc.(CTVA-N) Frequently Asked Questions

What is Corteva Inc. stock symbol?

Corteva Inc. is a American stock, trading under the symbol CTVA-N on the New York Stock Exchange (CTVA). It is usually referred to as NYSE:CTVA or CTVA-N

Is Corteva Inc. a buy or a sell?

In the last year, 2 stock analysts published opinions about CTVA-N. 2 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Corteva Inc..

Is Corteva Inc. a good investment or a top pick?

Corteva Inc. was recommended as a Top Pick by on . Read the latest stock experts ratings for Corteva Inc..

Why is Corteva Inc. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Corteva Inc. worth watching?

2 stock analysts on Stockchase covered Corteva Inc. In the last year. It is a trending stock that is worth watching.

What is Corteva Inc. stock price?

On 2025-03-20, Corteva Inc. (CTVA-N) stock closed at a price of $61.83.